214286-85-8

Upstream product

• 214286-84-7 [5-(2,2-dimethyl-8,8a-dihydro-3aH-indeno[1,2-d]oxazol-3-yl)-4-(4-fluoro-benzyl)-2-hydroxy-1-isobutyl-5-oxo-pentyl]-carbamic acid tert-butyl ester 
• 214286-81-4 3-(4'-fluorophenyl)propionic acid cis-(1''S,2''R)-1''-amino-2''-indanolacetonide amide 
• 772-70-3 3-(4-fluorophenyl)propanoyl chloride 
• 459-31-4 3-(4-fluorophenyl)propanoic acid 

Downstream Products

• 214286-87-0 (E)-(S)-4-[(2R,5S)-5-Cyclopentylsulfanylcarbonylamino-2-(4-fluoro-benzyl)-7-methyl-4-oxo-octanoylamino]-6-(trityl-carbamoyl)-hex-2-enoic acid ethyl ester 
• 214286-86-9 (E)-(S)-4-[(2R,5S)-5-tert-Butoxycarbonylamino-2-(4-fluoro-benzyl)-7-methyl-4-oxo-octanoylamino]-6-(trityl-carbamoyl)-hex-2-enoic acid ethyl ester 

Relevant academic research and scientific papers

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimetics

The structure-based design, chemical synthesis, and biological evaluation of various ketomethylene-containing human rhinovirus (HRV) 3C protease (3CP) inhibitors are described. These compounds are comprised of a peptidomimetic binding determinant and an e